ID

14145

Description

Comparison of Adjuvanted Hepatitis B Vaccine to Double Dose of Engerix™-B in Pre- /Haemodialysis Patients Aged ≥15 Years; ODM derived from: https://clinicaltrials.gov/show/NCT00383227

Link

https://clinicaltrials.gov/show/NCT00383227

Keywords

  1. 3/31/16 3/31/16 -
Uploaded on

March 31, 2016

DOI

To request one please log in.

License

Creative Commons BY 4.0

Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Hepatitis B NCT00383227

Eligibility Hepatitis B NCT00383227

Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
a male or female > = 15 years of age at the time of the first vaccination.
Description

Gender and age at the first vaccination

Data type

boolean

Alias
UMLS CUI [1]
C0079399
UMLS CUI [2,1]
C0001779
UMLS CUI [2,2]
C0419726
written informed consent obtained from the subject/ from the parents or guardians of the subject.
Description

Written informed consent

Data type

boolean

Alias
UMLS CUI [1]
C0021430
seronegative for anti-hbs antibodies, anti-hbc antibodies & hepatitis b surface antigen (hbsag).
Description

Anti-hbs antibodies, anti-hbc antibodies & hepatitis b surface antigen

Data type

boolean

Alias
UMLS CUI [1]
C0201478
UMLS CUI [2]
C0201480
UMLS CUI [3]
C0201477
if the subject was a female, she was of non-childbearing potential or, if of childbearing potential, she had to be abstinent or use adequate contraceptive precautions for one month prior to enrollment and up to two months after the last vaccination.
Description

Gynaecological status

Data type

boolean

Alias
UMLS CUI [1]
C3831118
UMLS CUI [2]
C0700589
pre-haemodialysis patient* or a patient on haemodialysis.
Description

Pre-haemodialysis or haemodialysis

Data type

boolean

Alias
UMLS CUI [1]
C1264634
UMLS CUI [2]
C0019004
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
use of any investigational or non-registered drug or vaccine other than the study vaccine during the study period or within 30 days preceding the first dose of study vaccine.
Description

Experimental drug

Data type

boolean

Alias
UMLS CUI [1]
C0304229
previous vaccination against hepatitis b.
Description

Hepatitis B vaccination

Data type

boolean

Alias
UMLS CUI [1]
C0474232
history of hepatitis b infection.
Description

Hepatitis b infection

Data type

boolean

Alias
UMLS CUI [1]
C0019163
known exposure to hepatitis b virus within 6 weeks. pregnant or lactating female
Description

HBV exposure

Data type

boolean

Alias
UMLS CUI [1,1]
C0019169
UMLS CUI [1,2]
C0332157
clinically abnormal alt/ast values (> 3 times normal values)
Description

Alt/ast values

Data type

boolean

Alias
UMLS CUI [1]
C0201836
UMLS CUI [2]
C0201899

Similar models

Eligibility Hepatitis B NCT00383227

Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
Gender and age at the first vaccination
Item
a male or female > = 15 years of age at the time of the first vaccination.
boolean
C0079399 (UMLS CUI [1])
C0001779 (UMLS CUI [2,1])
C0419726 (UMLS CUI [2,2])
Written informed consent
Item
written informed consent obtained from the subject/ from the parents or guardians of the subject.
boolean
C0021430 (UMLS CUI [1])
Anti-hbs antibodies, anti-hbc antibodies & hepatitis b surface antigen
Item
seronegative for anti-hbs antibodies, anti-hbc antibodies & hepatitis b surface antigen (hbsag).
boolean
C0201478 (UMLS CUI [1])
C0201480 (UMLS CUI [2])
C0201477 (UMLS CUI [3])
Gynaecological status
Item
if the subject was a female, she was of non-childbearing potential or, if of childbearing potential, she had to be abstinent or use adequate contraceptive precautions for one month prior to enrollment and up to two months after the last vaccination.
boolean
C3831118 (UMLS CUI [1])
C0700589 (UMLS CUI [2])
Pre-haemodialysis or haemodialysis
Item
pre-haemodialysis patient* or a patient on haemodialysis.
boolean
C1264634 (UMLS CUI [1])
C0019004 (UMLS CUI [2])
Item Group
C0680251 (UMLS CUI)
Experimental drug
Item
use of any investigational or non-registered drug or vaccine other than the study vaccine during the study period or within 30 days preceding the first dose of study vaccine.
boolean
C0304229 (UMLS CUI [1])
Hepatitis B vaccination
Item
previous vaccination against hepatitis b.
boolean
C0474232 (UMLS CUI [1])
Hepatitis b infection
Item
history of hepatitis b infection.
boolean
C0019163 (UMLS CUI [1])
HBV exposure
Item
known exposure to hepatitis b virus within 6 weeks. pregnant or lactating female
boolean
C0019169 (UMLS CUI [1,1])
C0332157 (UMLS CUI [1,2])
Alt/ast values
Item
clinically abnormal alt/ast values (> 3 times normal values)
boolean
C0201836 (UMLS CUI [1])
C0201899 (UMLS CUI [2])

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial